@NCSAUA Board Member Dr. James Brown and the section's Early Career Investigators Showcase nominees @Dr_i_pp_olito and @HitenDPatel selected for presentation at #AUA26.
New in our partnership with @DGlaucomflecken: the KEYNOTE-905 trial evaluated enfortumab vedotin plus pembrolizumab as perioperative therapy in patients with muscle-invasive bladder cancer who were ineligible to receive cisplatin. Read the full study for free: https://t.co/A1RikB7ZIo
#AUA26 is just 4 days away!
@NorthwesternMed Urology will be strongly represented at this year’s Annual Meeting by our faculty, residents, fellows, and medical students. We’re excited to share our work—and to connect with colleagues from around the world.
Meet our representatives and follow along for conference updates!
🔥 POISE-3 Urology published in European Urology 🚨
In the largest randomized placebo-controlled #urology analysis of #TranexamicAcid (TXA), #TXA reduced major #bleeding risk by 37% (from 9.5% to 6.1%) with no clear increase in #thrombosis
More at https://t.co/Yypy7vb9Jz
#EBM
A national VHA study found that prebiopsy prostate MRI utilization increased from 2% in 2015 to 41% in 2023 for veterans with elevated PSA, higher than national benchmarks. https://t.co/Yp0mvd501q
The hardest lessons after training aren’t always in the OR or clinic.
🙏 I wrote this essay for anyone navigating their first year as an attending.
“Unseen Scars” in @JAMA_current
🔗https://t.co/0e09Zx1nb6
The @NorthwesternMed Urology Department is celebrating 125 years of excellence! As we celebrate this historic anniversary, watch as we honor pioneers in the field and reflect on just some of the achievements that exemplify our dedication to better urology. #NMBetter
📰New in @UrolOncol!
💡Highlights:
1⃣Presence of EPE on MRI predicted prostatectomy outcomes
2⃣Combined biopsy showed the highest rate of grade concordance with prostatectomy
3⃣Our model for adverse surgical pat did not outperform existing nomograms
🔗https://t.co/Qjs3Ph8Wbk
Presented at #ASCO25:
A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results: https://t.co/j3kWJDjuVz
@ASCO
Strong Monday showing with Northwestern trainee presentations and the gold medal for the residency abstract Olympics at #AUA25@AmerUrological@NM_Urology